Abstract:Rationale & objective: Previous studies have illustrated the potential superiority of drug-coated balloons (DCBs) in maintaining patency after initial angioplasty for arteriovenous fistula (AVF) dysfunction due to stenosis. Our trial evaluated the efficacy and safety of DCBs for preventing fistula restenosis in Chinese hemodialysis patients. Study design: Multicenter, prospective, randomized, open-label, blinded end point, controlled trial. Settings & participants: A total of 161 hemodialysis patients with fistula dysfunction from 10 centers in China. Intervention: Participants were randomized 1:1 to treatment with initial dilation followed by DCB angioplasty or conventional high-pressure balloon (HPB) angioplasty. Outcomes: The primary end point was target lesion primary patency defined as the target lesion intervention-free survival in conjunction with an ultrasonography-measured peak systolic velocity ratio (PSVR) ≤2.0 at 6 months. The secondary end points included 1) device, technical, clinical, and procedural success; 2) major adverse events; 3) degree of target lesion stenosis at 6 months; and 4) clinically driven target lesion and target shunt revascularization within 12 months. Results: The percentage with target lesion primary patency as defined by a PSVR ≤2.0 was higher in the DCB group than in the control group (65% vs 37%, respectively; rate difference, 28% [95% CI, 13%-43%]; P <0.001) at 6 months. The target lesion and target shunt intervention-free survival of the DCB group were not superior to those of the control group at 6 months (P = 0.3 and P = 0.2, respectively) but were superior at 12 months (target lesion intervention-free survival: 73% for DCB vs 58% for control [P = 0.04]; target shunt intervention-free survival: 73% for DCB vs 57% for control [P = 0.04]). The average degree of target lesion stenoses at 6 months was not significantly different between the 2 groups (44% ± 16% for DCB vs 49% ± 18% for control; P = 0.09). There were no significant differences in major adverse events or in device, technical, clinical, or procedural success rates between the groups. Limitations: Small sample size; short follow-up period; procedural differences between the 2 groups such as unequal inflation times and balloon lengths. Conclusions: Compared to conventional HPB angioplasty, DCB treatment achieved superior primary patency defined using PSVR measured at 6 months and superior intervention-free survival of both the target lesion and the target shunt at 12 months without evidence of greater adverse events. Funding: Funded by ZhuHai Cardionovum Medical Device Co., Ltd. Trial registration: Registered at ClinicalTrials.gov with study number NCT02962141.

Application of 3D Hydrolysis Detachable Coils and Ordinary Coils in Percutaneous Closure of Coronary Artery Fistula

Interventional Occlusion of Congenital Vascular Malformations.

Clinical analysis of transcatheter closure of coronary artery fistula in middle and aged patients

Paclitaxel Coated Balloon Versus Conventional Balloon Angioplasty in Dysfunctional Dialysis Arteriovenous Fistula: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Comparison of Success Rate and Complications of Totally Percutaneous Decannulation in Patients with Veno-Arterial Extracorporeal Membrane Oxygenation and Endovascular Aneurysm Repair

Clinical Implication of Real-Time Three-Dimensional Transesophageal Echocardiography in Percutaneous Transcatheter Left Atrial Appendage Closure with Amplatzer Cardiac Plug(ACP) Device for Non-Valvular Atrial Fibrillation Patients

The Characteristics Of Coronary-Pulmonary Artery Fistulas And The Effectivity Of Trans-Catheter Closure: A Single Center Experience

Successful transcatheter coil embolization of a coronary cameral fistula in a young male with a structurally normal heart: A case report

Surgical and Transcatheter Coil Embolization Treatment of 94 Cases of Congenital Coronary Artery Fistula

Efficacy and Safety of Paclitaxel-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas: A Multicenter Randomized Controlled Trial

Diverse Transcatheter Closure Strategies in Coronary Artery Fistulas A State-of-the-Art Approach

Application of modified double-lumen microcatheter in the measurement of fractional flow reserve in coronary bifurcation lesions

Dose All of the Coronary Fistulas been Created by the Reopening Wire After Successful Revascularization of Chronic Total Occlusion?

Transcatheter closure of multiple coronary artery fistulas: a coronary computed tomography angiography-based anatomic classification

Application of Percolse, Angio-Seal Vascular Closure Devices or Manual Compression in Emergency Percutaneous Coronary Intervention

Nutritional Strategies to Mitigate Complications and Improve Long-Term Functionality of Autologous Arteriovenous Fistula Post Ultrasound and DSA Guided Balloon Dilation

Assessment of the Transcatheter Closure of Patent Ductus Arteriosus in Children

Drug-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Hemodialysis Fistulae

Percutaneous closure of giant aneurysmal coronary artery-to-coronary sinus fistulae with guidance from three-dimensional printed models: a case series

Comparison of drug‐coated balloon angioplasty versus common balloon angioplasty for arteriovenous fistula stenosis: A systematic review and meta‐analysis

Outcomes of transcatheter closure for coronary artery fistulas with or without aneurysm: A comparative study